TTK Healthcare Ltd-$

TTK Healthcare Ltd-$

TTK Healthcare Ltd has appointed M/s. R V K & Co as its Tax Auditor for a term of three years, from FY 2025-26 to 2027-28.

TTK Healthcare Ltd-$

TTK Healthcare Ltd has announced that M/s Aiyar & Co, their tax auditors, are unable to continue with the tax audit assignment for FY 2025-26 due to their peer review status. The company will initiate necessary action to appoint a new tax auditor.

TTK Healthcare Ltd-$

TTK Healthcare Ltd has published a newspaper advertisement regarding the opening of a special window for transfer and dematerialisation of physical securities, as per SEBI's Circular dated January 30, 2026.

TTK Healthcare Ltd-$

TTK Healthcare Ltd. has announced its unaudited financial results for the first quarter ended June 30, 2026, which were reviewed by the Audit Committee and approved by the Board of Directors. The company reported a revenue from operations of Rs. 25,755.76 lakhs, a total income of Rs. 27,435.23 lakhs, and a profit before exceptional items and tax of Rs. 2,885.83 lakhs. The company has also received orders for inventory amounting to Rs. 94.63 lakhs, which were written off in FY 2024-25.

TTK Healthcare Ltd-$

TTK Healthcare Ltd has announced its unaudited financial results for the first quarter ended June 30, 2026, with revenue from operations at Rs. 25,755.76 lakhs and profit before tax at Rs. 2,885.83 lakhs.

TTK Healthcare Ltd-$

TTK Healthcare Ltd has scheduled a Board Meeting on August 06, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, and the trading window for designated persons and their relatives is closed from July 01, 2026, to August 08, 2026.

TTK Healthcare Ltd-$

TTK Healthcare Ltd held its 68th Annual General Meeting on July 24, 2026, where all resolutions were passed, including the adoption of audited financial statements, declaration of a 100% dividend, and reappointment of directors.

TTK Healthcare Ltd-$

TTK Healthcare Ltd. held its 68th Annual General Meeting on July 24, 2026, where the Chairman's speech highlighted the company's performance for the year 2025-26. The company reported a 7% growth in revenue from operations, but a drop in pre-tax profit due to lower profit from the Protective Devices Division. The company has entered into a definitive agreement to sell its EVA and Good Home brands to Wipro Enterprises Private Limited for Rs. 256 crores. The company has also launched a new campaign for Woodward's Gripe Water and plans to expand its 'Care' portfolio with the launch of Tummy Tonic in Tamil Nadu.

TTK Healthcare Ltd-$

TTK Healthcare Ltd held its 68th Annual General Meeting through video conferencing, with the Chairman Mr. T T Raghunathan chairing the meeting. The meeting approved the audited financial statements, declared a dividend of Rs.10 per share, and reappointed Mr. Krishnamurthy Shankaran as Director and Mr. T T Raghunathan as Executive Chairman for a further term. The meeting also ratified the remuneration payable to the Cost Auditors.

TTK Healthcare Ltd-$

TTK Healthcare Ltd-$ disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Board of Directors approved the proposal for the sale of 'EVA' and 'Good Home' brands to M/s Wipro Enterprises Private Limited, with the closing of the transaction subject to the fulfilment of 'conditions precedent'.

TTK Healthcare Ltd-$

TTK Healthcare Ltd announced the sale of its 'EVA' and 'Good Home' brands to Wipro Enterprises Private Limited, with a consideration of Rs.256 crores. The transaction is subject to customary conditions and is expected to be completed by September 30, 2026.

TTK Healthcare Ltd-$

TTK Healthcare Ltd has announced the closure of its trading window for designated persons and their immediate relatives, effective from July 01, 2026. This closure is mandated by SEBI (Prohibition of Insider Trading) Regulations and the company's Code of Conduct, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the first quarter ending June 30, 2026. The date for the board meeting to approve these results will be intimated later.